Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$554M |
| 2 |
Microsoft
MSFT
|
+$470M |
| 3 |
Apple
AAPL
|
+$398M |
| 4 |
Amazon
AMZN
|
+$389M |
| 5 |
Merck
MRK
|
+$306M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$477M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
Philip Morris
PM
|
+$240M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$228M |
Sector Composition
| 1 | Technology | 26.15% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
2701
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $4.29M | ﹤0.01% |
556,207
+70,457
| +15% | +$544K |
|
2702
Janux Therapeutics
JANX
$1.45B
| $4.29M | ﹤0.01% |
354,585
+14,788
| +4% | +$179K |
|
2703
Southern First Bancshares
SFST
$366M
| $4.29M | ﹤0.01% |
139,686
+5,771
| +4% | +$177K |
|
|
BELFB
2704
Bel Fuse Class B
BELFB
$1.79B
| $4.29M | ﹤0.01% |
114,097
+2,675
| +2% | +$101K |
|
2705
First Business Financial Services
FBIZ
$431M
| $4.28M | ﹤0.01% |
140,316
+3,193
| +2% | +$97.4K |
|
2706
Northeast Bank
NBN
$941M
| $4.28M | ﹤0.01% |
127,182
+3,248
| +3% | +$109K |
|
2707
BrightView Holdings
BV
$1.32B
| $4.27M | ﹤0.01% |
759,402
+5,306
| +0.7% | +$29.8K |
|
2708
Aura Biosciences
AURA
$384M
| $4.25M | ﹤0.01% |
457,908
+157,435
| +52% | +$1.46M |
|
2709
Teekay
TK
$722M
| $4.25M | ﹤0.01% |
687,223
+36,046
| +6% | +$223K |
|
2710
Inovio Pharmaceuticals
INO
$126M
| $4.24M | ﹤0.01% |
431,398
+23,888
| +6% | +$235K |
|
2711
Ouster
OUST
$1.67B
| $4.24M | ﹤0.01% |
507,106
+291,003
| +135% | +$2.43M |
|
2712
Methanex
MEOH
$3.04B
| $4.24M | ﹤0.01% |
91,090
+422
| +0.5% | +$19.6K |
|
2713
Guaranty Bancshares
GNTY
$557M
| $4.22M | ﹤0.01% |
151,589
-1,288
| -0.8% | -$35.9K |
|
2714
Global E Online
GLBE
$6.06B
| $4.21M | ﹤0.01% |
130,530
+222
| +0.2% | +$7.16K |
|
2715
Bridgewater Bancshares
BWB
$457M
| $4.2M | ﹤0.01% |
387,574
+10,334
| +3% | +$112K |
|
2716
Vivid Seats
SEAT
$110M
| $4.19M | ﹤0.01% |
27,487
+1,964
| +8% | +$300K |
|
2717
Sight Sciences
SGHT
$181M
| $4.19M | ﹤0.01% |
479,798
+12,524
| +3% | +$109K |
|
2718
Lexicon Pharmaceuticals
LXRX
$418M
| $4.19M | ﹤0.01% |
1,725,409
+117,468
| +7% | +$285K |
|
2719
MVB Financial
MVBF
$305M
| $4.15M | ﹤0.01% |
201,066
+12,489
| +7% | +$258K |
|
2720
Mercer International
MERC
$206M
| $4.14M | ﹤0.01% |
423,738
+6,642
| +2% | +$64.9K |
|
2721
Xeris Biopharma Holdings
XERS
$1.21B
| $4.13M | ﹤0.01% |
2,530,705
+97,994
| +4% | +$160K |
|
2722
RBB Bancorp
RBB
$332M
| $4.12M | ﹤0.01% |
265,847
+10,812
| +4% | +$168K |
|
|
GOEV
2723
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $4.11M | ﹤0.01% |
13,691
+5,009
| +58% | +$1.5M |
|
2724
Regional Management Corp
RM
$418M
| $4.09M | ﹤0.01% |
156,618
+4,763
| +3% | +$124K |
|
2725
Ranpak Holdings
PACK
$395M
| $4.08M | ﹤0.01% |
781,179
+22,252
| +3% | +$116K |
|